BioTB
Dr. Adhip Arora, Oncologist in Sector-5, Rohini, New Delhi
Oncology

Dr. Adhip Arora

Consultant, Medical Oncology

7.7
TrustScore™Very Good
Ranked #61 of 243 in New Delhi
Sector-5, Rohini, New Delhi7 years' experience

About

Dr. Adhip Arora works as a Consultant in the Medical Oncology department at Rajiv Gandhi Cancer Institute & Research Centre in Sector-5, Rohini, Delhi. He completed an MBBS at VMMC & SJH, Delhi, in 2019, an MD in General Medicine from the same institution in 2022, and a DM in Medical Oncology at AIIMS, New Delhi.

Dr. Adhip Arora treats solid tumours and haematological malignancies, which are cancers of the blood and blood-forming tissues. Special interests include breast, gastrointestinal, thoracic, head and neck, genitourinary and gynaecologic oncology. He also works in precision oncology, immunotherapy and targeted therapy, clinical trials and translational research, and supportive oncology.

Dr. Adhip Arora has received the Outstanding Research Award at AIIMS Research Day. Earlier positions include Resident in Medical Oncology at AIIMS, Delhi, and Resident in Medicine at Safdarjung Hospital, Delhi. Publications include work on the PLANeT trial, a study of low-dose pembrolizumab with chemotherapy for triple-negative breast cancer, published in Ann Oncol in 2025.

Qualifications

MBBS
VMMC & SJH, Delhi
MD (General Medicine)
VMMC &SJH, Delhi
DM (Medical Oncology)
AIIMS, New Delhi

Awards & recognition

Outstanding Research Award, AIIMS Research DayFirst Prize, Best of St. Gallen Breast Cancer Symposium (SGBCS), Kolkata

Publications

A phase II, randomized, open-label study to evaluate low-dose pembrolizumab plus chemotherapy versus chemotherapy as neoadjuvant therapy for localized triple-negative breast cancer (PLANeT trial—Pembrolizumab Low Dose in Addition to NACT in TNBC)

Ann Oncol (2025)

Health-related quality of life with low-dose pembrolizumab plus chemotherapy in early triple-negative breast cancer: findings from the PLANeT trial

J Clin Oncol (2026)

A phase II, randomized, open-label study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC)

Trials (2025)

266TiP: A phase II, randomized, open-labelled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC)

ESMO Open (2025)

Correlation of carotid artery intima-media thickness with parameters of mineral bone disorder in patients with chronic kidney disease

Natl Med J India (2026)

Correlation of fibroblast growth factor 23 and malnutrition in chronic kidney disease patients on maintenance hemodialysis

J Assoc Physicians India (2022)

Nephron index (urinary phosphate: serum fibroblast growth factor 23 ratio): a marker for atherosclerosis in diabetic predialysis chronic kidney disease patients

J Assoc Physicians India (2022)

Isolated miliary tuberculosis of brain in an immuno-competent patient presenting as cerebellar ataxia

International Journal of Medical Science and Diagnosis Research (2022)

Multiorgan failure due to paraquat poisoning: Case report and review of literature

Journal of Medical Science and Clinical Research (2020)

Conditions treated

solid malignancieshematological malignancies

BioTB TrustScore™ Analysis

Very Good

Ranked #61 of 243 oncology specialists in New Delhi

Top 26% in New Delhi#16 of 52 in Sector-5, RohiniAnalysis dated 2026-10-21

Score breakdown

  • Credentials & training (25%)8.5/10

    postgraduate degree and super-specialty training

  • Experience & seniority (20%)5.6/10

    7 years in practice

  • Hospital standing (20%)8.4/10

    Rajiv Gandhi Cancer Institute & Research Centre and NABH and NABL accredited

  • Practice depth (15%)10.0/10

    2 conditions treated and academic or award record

  • Access & transparency (10%)3.0/10

    direct contact number

  • Profile completeness (10%)9.8/10

    reviewed in the last 90 days

Strengths

  • Practice depth: 2 conditions treated and academic or award record
  • Profile completeness: reviewed in the last 90 days
  • Credentials & training: postgraduate degree and super-specialty training

Check before you visit

  • Experience & seniority: 7 years in practice
  • Access & transparency: direct contact number

BioTB analysis

Dr. Adhip Arora ranks #61 of 243 oncology specialists in New Delhi on the BioTB TrustScore™, placing in the top 26%. The score of 7.7 (Very Good) is driven most by practice depth (10/10: 2 conditions treated and academic or award record). The main gap is access & transparency (3/10: direct contact number), so confirm those details with the hospital before you visit.

TrustScore™ is computed by the BioTB analysis engine from the facts on this profile, weighted as shown above, and re-ranked against every other oncology specialist in New Delhi. How TrustScore™ works

Practice Location & Google Map

Address and map for this listing. Confirm before you visit.

Complete Physical Address

D-18, Sector-5, Rohini, Delhi-110085

PIN: 110085Locality: Sector-5, RohiniCity: New Delhi, DelhiGPS: 28.7164° N, 77.1109° E
Navigation Actions
Get Directions

Patient Reviews0

No pay-to-rank.

BioTB TrustScore™

7.7
TrustScore™Very Good
Ranked #61 of 243 in New Delhi
Score CompositionWeight
Credentials & training:8.5/10 (25%)
Experience & seniority:5.6/10 (20%)
Hospital standing:8.4/10 (20%)
Practice depth:10.0/10 (15%)
Access & transparency:3.0/10 (10%)
Profile completeness:9.8/10 (10%)

Computed by the BioTB analysis engine from this profile's facts and ranked against every doctor of the same specialty in New Delhi. Full analysis

Consultation details

Consultation feeNot listed
OPD timings

Timings not listed. Call the clinic to confirm OPD days.

AddressDirections

D-18, Sector-5, Rohini, Delhi-110085

View on Google Maps
BioTB editorial standard

Every fact on this profile is sourced from the hospital or clinic's official website and other authoritative public pages, curated by the BioTB editorial team, scored by the TrustScore™ engine and dated at its last review. Rankings cannot be bought.

Where this information comes from

Last reviewed

Details such as timings and fees can change, so please confirm with the clinic before you visit. If you are this doctor and something is out of date, request an update. Spotted a mistake? Tell us.

Questions about Dr. Adhip Arora

Where does Dr. Adhip Arora consult?

Dr. Adhip Arora consults at Rajiv Gandhi Cancer Institute & Research Centre in Sector-5, Rohini, Delhi.

What are Dr. Adhip Arora's qualifications?

Dr. Adhip Arora holds an MBBS from VMMC & SJH, Delhi (2019), an MD in General Medicine from the same institution (2022) and a DM in Medical Oncology from AIIMS, New Delhi.

Which conditions does Dr. Adhip Arora treat?

Dr. Adhip Arora treats solid tumours and haematological malignancies. Special interests include breast, gastrointestinal, thoracic, head and neck, genitourinary and gynaecologic oncology.

More in Delhi NCR
All oncologists in Delhi
Dr. Sudhir Kumar Rawal, Oncology in Sector-5, Rohini, New Delhi
Oncology

Dr. Sudhir Kumar Rawal

Chief of GenitoUro – Oncology Services, Uro-Genito Oncology

M.B.B.S., M.S., M.Ch. (Urology), DNB (Urology), Fellowship of CPDR

Dr. Sudhir Kumar Rawal, Uro-Genito Oncology at Rajiv Gandhi Cancer Institute & Research Centre, Delhi, with 36 years of experience and an M.Ch. (Urology).

Sector-5, Rohini, New Delhi
Map
36+ Years Clinical Experience
cancers of the genitourinary systemuro-gynecological cancers
8.8TrustScore™#7
Consultation: Fee not listed
View Profile
Dr. A.K. Dewan, Oncology in Sector-5, Rohini, New Delhi
Oncology

Dr. A.K. Dewan

Principal Director, Surgical Oncology

MBBS, MS, M.Ch., Post-doctoral course in Hospital management

Dr. A.K. Dewan, Surgical Oncology at Rajiv Gandhi Cancer Institute & Research Centre, Delhi, with 40 years of experience in cancer surgery.

Sector-5, Rohini, New Delhi
Map
40+ Years Clinical Experience
Oral CancerLaryngeal CancerOropharyngeal Cancer
8.6TrustScore™#10
Consultation: Fee not listed
View Profile
Dr. Shivendra Singh, Oncology in Sector-5, Rohini, New Delhi
Oncology

Dr. Shivendra Singh

Director, Surgical Oncology & Chief, GI & HPB Onco Surgery, GI & HPB Onco Surgery

MBBS, MS (General Surgery), DNB (General Surgery), M.Ch. (Gastrointestinal Surgery), Clinical Fellow (Department of HPB Surgery & Liver Transplantation), Clinical Fellow (Department of Digestive Surgery), Clinical Fellow (Division of Liver Transplantation & Hepatobiliary Surgery)

Dr. Shivendra Singh, Oncology at Rajiv Gandhi Cancer Institute & Research Centre, Delhi, with 28 years of experience and a DNB (General Surgery).

Sector-5, Rohini, New Delhi
Map
28+ Years Clinical Experience
liver & pancreatic tumorsgallbladder cancerGI malignancies
8.6TrustScore™#17
Consultation: Fee not listed
View Profile